Ocean Biomedical, Inc. SEC filings OCEA

Ocean Biomedical, Inc. has 255 filings in SEC EDGAR's recent list, going back to Jul 19, 2021. Its latest annual report, Form 10-K, was filed on Apr 8, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 15, 2025, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Aug 5, 2025 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Jan 13, 2025 Sep 30, 2024
10-Q Quarterly report Dec 23, 2024 Jun 30, 2024
10-Q Quarterly report Dec 23, 2024 Mar 31, 2024
10-Q Quarterly report Apr 15, 2024 Sep 30, 2023
10-Q/A Amended quarterly report Apr 15, 2024 Jun 30, 2023
10-Q/A Amended quarterly report Apr 15, 2024 Mar 31, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 24, 2023 Mar 31, 2023
10-Q Quarterly report Oct 17, 2022 Sep 30, 2022
10-Q Quarterly report Jul 11, 2022 Jun 30, 2022
10-Q Quarterly report Apr 25, 2022 Mar 31, 2022
10-Q Quarterly report Oct 18, 2021 Sep 30, 2021

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OCEA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1869974
Former names
Ocean Biomedical, Inc./DE (until Feb 15, 2023); Aesther Healthcare Acquisition Corp. (until Feb 14, 2023)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.